Paige, a startup building computational pathology products designed to help cancer care teams can make faster, more informed treatment decisions for their patients, has raised $20 million in new funding, led by Goldman Sachs. This brings Paige's Series B funding to $70 million and its overall funding to over $95 million. Leo Grady, CEO of Paige, joined Cheddar to explain how his company is utilizing artificial intelligence to help in the fight against cancer.